David F Burgstahler is Director of Syneos Health, Inc.. Currently has a direct ownership of 38,758 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on May 23, 2017, when has been sold 2,693 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.8K
0% 3M change
0% 12M change
Total Value Held $0

David F Burgstahler Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2017
BUY
Grant, award, or other acquisition
-
2,693 Added 6.5%
38,758 Class A Common Stock
Sep 19 2016
BUY
Open market or private purchase
$43,190 $43.19 p/Share
1,000 Added 2.7%
36,065 Class A Common Stock
Sep 15 2016
BUY
Grant, award, or other acquisition
-
1,729 Added 4.7%
35,065 Class A Common Stock
Aug 24 2016
BUY
Other acquisition or disposition
-
33,336 Added 50.0%
33,336 Common Stock, par valu...

Also insider at

RVLP
RVL Pharmaceuticals plc Healthcare
DFB

David F Burgstahler

Director
Raleigh, NC

Track Institutional and Insider Activities on SYNH

Follow Syneos Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

News

Receive news related to Syneos Health, Inc.

Track Activities on SYNH